How to Help Your Patients Save Money on Eyemycin: A Provider's Guide to Savings Programs

Erythromycin ophthalmic ointment is one of the more affordable ophthalmic antibiotics — but during shortage periods, the combination of limited availability and variable insurance coverage can create unexpected cost barriers for patients. This guide helps you navigate cost conversations and point patients toward the right resources.

Understanding the Cost Landscape for Erythromycin Ophthalmic Ointment

As a generic medication, erythromycin ophthalmic ointment is generally affordable compared to brand-name alternatives. Key pricing benchmarks:

Retail cash price: $15–$42 for a 3.5g tube, depending on pharmacy and location

With GoodRx: Approximately $14–$18 at participating pharmacies

With SingleCare: As low as $12.99 per 3.5g tube at participating pharmacies

With commercial insurance: Typically Tier 1 or Tier 2 formulary placement; copays usually $0–$20

Medicare Part D: Generally covered; Part D copay typically $0–$10 for Tier 1 generics

Medicaid: Covered in most states; copay often $0–$3

Key Prescribing Strategies to Reduce Patient Cost

Always prescribe generically. Write 'erythromycin ophthalmic ointment 0.5%' — never by brand name (all brand names including Eyemycin, Ilotycin, and Roymicin are discontinued). Generic prescriptions are automatically filled at the lowest-cost equivalent, maximizing insurance coverage and discount card applicability.

Prescribe the appropriate quantity. A standard 3.5g tube provides more than enough ointment for a complete 5–10 day treatment course. Prescribing one 3.5g tube avoids unnecessary refills and keeps costs low.

Consider the 90-day supply option for long-term use. For patients using erythromycin ointment longer-term (e.g., for blepharitis), a 90-day supply via mail-order pharmacy may reduce cost. Check with the patient's insurer for coverage.

Insurance Coverage Considerations

Generic erythromycin ophthalmic ointment is generally well-covered on most commercial, Medicare, and Medicaid formularies. However, there are situations where coverage may be denied or restricted:

Step therapy (Medicaid): Some Medicaid programs require step therapy for ophthalmic antibiotics. If this applies, documenting the specific indication (particularly neonatal use or infection characteristics) can help obtain coverage.

Quantity limits: Some plans limit the number of tubes per fill. If a patient needs multiple tubes for extended therapy, a prior authorization with clinical documentation may be necessary.

Prior authorization for related medications: If you're switching a patient to an alternative (e.g., AzaSite) due to the shortage, be aware that brand-name alternatives may require prior authorization.

Discount Programs to Share With Your Patients

Because erythromycin ophthalmic is a generic, manufacturer-branded savings programs are not available. However, several third-party programs can significantly reduce patient out-of-pocket costs:

GoodRx (goodrx.com): Free discount card; reduces price to $14–$18 at many pharmacies. No enrollment required.

SingleCare (singlecare.com): Reduces price to as low as $12.99 per tube at participating pharmacies. Free to use.

Optum Perks: Another free discount card; competitive pricing at many major chains and independents.

NeedyMeds.org: Lists patient assistance programs and state programs for low-income or uninsured patients. Especially valuable for patients with no coverage.

Community Health Centers (FQHCs): For patients without insurance, referring them to a Federally Qualified Health Center provides sliding-scale prescription access.

When Erythromycin Is Unavailable: Cost-Effective Alternatives

During shortage periods, the cost of alternatives matters too. Here's a quick cost comparison:

Tobramycin 0.3% drops (generic): $10–$30 cash; Tier 1 generic on most plans

Ciprofloxacin 0.3% drops (generic): $10–$30 cash; widely available; Tier 1 on most plans

AzaSite (azithromycin 1%, brand only): $200+ cash; may require prior authorization; itself in shortage

For clinical details on managing the shortage and prescribing alternatives, see our Eyemycin shortage briefing for providers. To help patients find available stock near them before sending a prescription, use medfinder for Providers.